cardiac arrhythmia explained as Cardiac is heart and Arrhythmia is an irregular rhythm of heartbeats. Covid19 pandemic highlights the yearn for monitoring devices concerned with heart health. Recent studies have exhibited novel corona severely affects cardiovascular health to a greater extent. According to the American Heart Association (AHA), more than 800 Thousand individuals die from cardiovascular diseases in the United States yearly and about 92.1 million Americans exist with some of the other forms of cardiovascular disease.
When the heartbeat rhythm is faster than normal in adults it is known as Tachycardia. It is usually 100 beats per minute in adults when it is diagnosed as Tachycardia. As stated by AHA about 90 000 cases of Supraventricular tachycardia are detected annually in the United States. When the heartbeat rhythm is too slow than the normal rate in adults it is known as Bradycardia. It is usually below 60 beats per minute in adults when it is diagnosed as Bradycardia. Whereas an irregular heartbeat rhythm in the atria is referred to as Atrial fibrillation is recognized as the more common form of cardiac arrhythmia. As estimated by the AHA trial, fibrillation has affected at least 2.3 million people in the United States alone and is associated with increased risks of stroke and mortality.
Paroxysmal Supraventricular Tachycardia (PSVT) is caused when an abnormal electrical connection between atria and ventricles causes a rapid heart rhythm that starts and stops abruptly. Even though the majority of the population in the United States of America is impaired by PSVT yet it is difficult to diagnose, as articulated by the American Heart Association. Cardiac health monitoring devices play an extensive role in cardiac health.
Cardiac Arrhythmia Monitoring Devices Market Value Share Analysis, by Geography (2021)
The report titled “Cardiac Arrhythmia Monitoring Devices Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global cardiac arrhythmia monitoring devices market . Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on cardiac arrhythmia monitoring devices market. Further, market share of prominent companies in the global cardiac arrhythmia monitoring devices market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Aerosol Cans companies. The global cardiac arrhythmia monitoring devices market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the cardiac arrhythmia monitoring devices market business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global cardiac arrhythmia monitoring devices market. Based on geography, the global cardiac arrhythmia monitoring devices market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada, and Mexico. Europe is sub-segmented into Germany, United Kingdom, Italy, France, and Spain. Asia Pacific (APAC) is sub-segmented into China, Japan, India, Australia, and South Korea. Middle East & Africa(MEA) is further segmented into Saudi Arabia, UAE, and South Africa. South America is sub-segmented into Brazil and Argentina.
The key players of the cardiac arrhythmia monitoring devices market are Boston Scientific Corporation, Medtronic, Biosense Webster, Inc (Johnson and Johnson), Siemens AG, Edwards Life sciences Corporation, Abbott, and General Electric Company.
Segmentation of cardiac arrhythmia monitoring devices market:
By End User
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved